Herbs Group Schedules 18 June 2026 AGM; Proposes Director Re-elections, KPMG Reappointment and New Share Mandates

Bulletin Express
04/29

Herbs Generation Group Holdings Limited (Herbs Group) has issued its proxy form and notice for the Annual General Meeting (AGM) to be held on 18 June 2026 at 4:00 p.m. at Units A7 & A8, 6/F, NCB Innovation Centre, 888 Lai Chi Kok Road, Kowloon, Hong Kong.

Seven ordinary resolutions will be tabled:

1. Financial Statements: Shareholders will vote on receiving and adopting the audited consolidated financial statements together with the directors’ and auditor’s reports for the financial year ended 31 December 2025.

2. Board Composition: The meeting will consider the re-election of three directors—Mr Kwok Chun On as Non-executive Director, and Mr Lam Yiu Por and Dr Tsang Hing Lim Kenneth as Independent Non-executive Directors.

3. Directors’ Remuneration: Authority will be sought for the board to determine directors’ remuneration.

4. Auditor: The board proposes the re-appointment of KPMG as external auditor and requests shareholder authorisation to fix the audit fee.

5. Share Repurchase Mandate: A general mandate allowing the board to repurchase shares representing up to 10% of the company’s issued share capital will be put to vote.

6. Share Issuance Mandate: A separate mandate would permit the board to allot, issue and deal with additional shares not exceeding 20% of the issued share capital.

7. Extension of Issuance Mandate: Subject to the passing of the previous two mandates, the issuance mandate may be extended by the number of shares repurchased under the repurchase authority.

Shareholders who wish to appoint a proxy must return the completed proxy form to Computershare Hong Kong Investor Services Limited no later than 48 hours before the meeting. Attendance in person remains permissible despite submission of a proxy form.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10